期刊文献+

Effects of Huachansu capsules combined with raltitrexed and olisaplatin on advanced colorectal cancer immunity, tumor markers, matrix metalloproteinases and angiogenesis

下载PDF
导出
摘要 Objective:To investigate the effects of Huachansu capsules combined with raltitrexed and olisaplatin on advanced colorectal cancer immunity, tumor markers, matrix metalloproteinases and angiogenesis.Methods: Eighty-two patients with advanced colorectal cancer who were treated in our hospital from August 2015 to September 2017 were randomly divided into the control group (41 cases) and the observation group (41 cases), the control group was treated with raltitrex plus oxaliplatin, on the basis of the control group, the observation group was treated with Huachansu Capsule. The levels of immune function, tumor markers, matrix metalloproteinases and angiogenic factors were compared before and after treatment in two groups of patients with advanced colorectal cancer.Results: After treatment, the levels of CD4+ and CD4+/CD8+ in the two groups were significantly higher than those before treatment (P<0.05), and the levels of CD4+ and CD4+/CD8+ in the observation group were significantly higher than those in the control group (P<0.05). the levels of CA125, CA19-9 and CEA in the two groups were significantly lower than those before treatment (P<0.05), and the levels of CA125, CA19-9 and CEA in the observation group were significantly lower than those in the control group (P<0.05);the levels of MMP-2 and MMP-9 in the two groups were significantly lower than those before treatment (P<0.05), and the levels of MMP-2 and MMP-9 in the observation group were significantly lower than those in the control group (P<0.05);the levels of VEGF, HIF-1α and TGF-β1 in the two groups were significantly lower than those before treatment (P<0.05), and the levels of VEGF, HIF-1α and TGF-β1 in the observation group were significantly lower than those in the control group (P<0.05).Conclusions: Huachansu Capsule combined with retidoxed and olixaplatin chemotherapy regimen can enhance the immune function of patients with advanced colorectal cancer, reduce the level of tumor markers in serum, inhibit the growth and metastasis of tumor cells and angiogenesis, which has clinical significance.
出处 《Journal of Hainan Medical University》 2018年第23期46-49,共4页 海南医学院学报(英文版)
  • 相关文献

参考文献3

二级参考文献147

  • 1rpád V Patai,Béla Molnár,Zsolt Tulassay,Ferenc Sipos.Serrated pathway:Alternative route to colorectal cancer[J].World Journal of Gastroenterology,2013,19(5):607-615. 被引量:5
  • 2刘志新.阿普唑仑治疗药源性顽固性呃逆疗效观察[J].中国药房,2004,15(8):494-495. 被引量:13
  • 3Lars Henrik Jensen,Anders Aamann Rasmussen,Lene Byriel,Hidekazu Kuramochi,Dorthe Gylling Crüger,Jan Lindebjerg,Peter V. Danenberg,Anders Jakobsen,Kathleen Danenberg.Regulation of MLH1 mRNA and protein expression by promoter methylation in primary colorectal cancer: a descriptive and prognostic cancer marker study[J].Cellular Oncology.2013(5)
  • 4Maria S. Pino,Daniel C. Chung.The Chromosomal Instability Pathway in Colon Cancer[J].Gastroenterology.2010(6)
  • 5Barbara Leggett,Vicki Whitehall.Role of the Serrated Pathway in Colorectal Cancer Pathogenesis[J].Gastroenterology.2010(6)
  • 6Eric R. Fearon.Molecular Genetics of Colorectal Cancer[J].Annual Review of Pathology: Mechanisms of Disease.2011
  • 7Wade S. Samowitz,Hans Albertsen,Jennifer Herrick,Theodore R. Levin,Carol Sweeney,Maureen A. Murtaugh,Roger K. Wolff,Martha L. Slattery.Evaluation of a Large, Population-Based Sample Supports a CpG Island Methylator Phenotype in Colon Cancer[J].Gastroenterology.2005(3)
  • 8Kevin J. Spring,Zhen Zhen Zhao,Rozemary Karamatic,Michael D. Walsh,Vicki L.J. Whitehall,Tanya Pike,Lisa A. Simms,Joanne Young,Michael James,Grant W. Montgomery,Mark Appleyard,David Hewett,Kazutomo Togashi,Jeremy R. Jass,Barbara A. Leggett.High Prevalence of Sessile Serrated Adenomas With BRAF Mutations: A Prospective Study of Patients Undergoing Colonoscopy[J].Gastroenterology.2006(5)
  • 9Liu Y,Wu W,Hong W,et al.Raltitrexed-based chemotherapy for advanced colorectal cancer[J].Clin Res Hepatol Gastroenterol,2014,38(2):219-225.
  • 10World Health Organization.Handbook for Reporting Results of Cancer Treatment (WHO Offset Publications)[M].Geneva:World Health Organization,1980.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部